Dr. Wasim Khan, MD, MPH: Advancing Immuno-Oncology Research in Parsippany, NJ
Pioneering Innovative Cancer Therapies with a Focus on Immunotherapy and Prevention
Dr. Wasim Khan, MD, MPH, is a distinguished physician and researcher specializing in immuno-oncology. With a robust background in drug safety and clinical research, he has held pivotal roles at leading biopharmaceutical companies, including Amgen, Bristol-Myers Squibb, Bayer, Celularity, Istari Oncology, Johnson & Johnson, Novartis, Pfizer, and Schering-Plough (Merck), recognized with Business Excellence in Clinical Development & Regulatory Affairs Award. His expertise encompasses oncology and immunology, where he has contributed significantly to the development and safety evaluation of novel immuno-oncology therapies, some of which were cited in the Nobel Prize for Medicine (a rare exception according to the Nobel Laureate, Dr. Allison) after successful NDAs. With the advent of targeted therapies and immuno-oncology (promoting the body’s immune self-defence against malignancies), cancer treatment is undergoing a revolution in reduced toxicity and improved prognosis in all types of cancers, including the deadly lung cancer.
Dr. Khan’s academic journey began with an undergraduate pre-med degree from Lucknow Christian College, followed by medical school at King George’s Medical College in 1982. He further honed his expertise with a fellowship in Clinical Immunology at the All India Institute of Medical Sciences (AIIMS) in New Delhi. His commitment to advancing medical knowledge led him to complete seven years of post-graduate studies at Harvard University in Cancer Epidemiology with Physicians’ Health Study and Nurses’ Health Study, focusing on cancer prevention and treatment strategies many of which have become standard of care in oncology clinics all over the world and remain the first-in-line benefiting our patients for years to come.
In addition to his clinical and academic achievements, Dr. Khan has been actively involved in public service and took the initiative on health care reform at Harvard Business School at the prompting of a Rhodes Scholar, Dr. Pasricha, an idea championed by the First Lady Hillary Clinton. Dr. Khan was twice nominated for the New Jersey State Senate in 2007 and 2011, aiming to influence healthcare policy and advocacy for the reduction of healthcare costs through preventive measures for alcohol and drug abuse in youth with MADD and John Dewey’s ideas of progressive education with NJEA. Although he was not elected, his campaigns highlighted his dedication to improving public health and healthcare accessibility and reducing the carbon footprint.
Currently based in Parsippany, NJ, Dr. Khan continues to contribute to the field of immuno-oncology through his research and professional endeavors. His work exemplifies a commitment to advancing cancer treatment and prevention, with a focus on innovative approaches to immunotherapy and personalized medicine.
Dr. Khan is a member of the American College of Physicians (ACP). American Association of Physicians of Indian-origin (AAPI), American Association for Advancement of Science (AAAS), American Society of Clinical Oncology (ASCO), and Society for Immunotherapy for Cancer (SITC).
Learn More about Dr. Wasim Khan:
Through his findatopdoc profile, https://www.findatopdoc.com/doctor/1654742-Wasim-Khan-Internist
About FindaTopDoc.com
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey towards optimal health by providing you with the know-how to make informed decisions for you and your family.
